Skip to main content

Lupus Nephritis

  • Chapter
Multisystem Diseases

Part of the book series: New Clinical Applications: Nephrology ((NCNG,volume 7))

  • 34 Accesses

Abstract

Nephritis in systemic lupus erythematosus represents the archetype of variable organ involvement of a disease. Our knowledge of the natural history of lupus nephritis has significantly improved in the last decade. There has been continuing refinement in histological classification, coupled with the recognition that the morphologically distinct glomerulopathies can have features of prognostic significance in common. Studies have demonstrated efficacy of immunosuppressive drugs in preserving renal function and reducing renal scarring, but consensus is lacking on the precise way in which the therapeutic regimes should be used. Most analyses have used either end-stage renal failure or death as a measure of outcome. Yet, the most common problems with which the clinician is faced are optimizing treatment of chronic, indolent or inactive disease whilst attempting to prevent the acute, possibly life-threatening flares of systemic lupus with nephritis. Recognition that acute deterioration in renal function in lupus nephritis is common proves the necessity for vigilance in management of each phase of the disease and indicates the need for a detailed, sensitive interpretation of the therapeutic needs of the individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tan, E. M., Cohen, A. S. and Fries, J. F. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 11, 1271–1277

    Article  PubMed  CAS  Google Scholar 

  2. Baldwin, D. S., Gluck, M. C. and Lowenstein, J. (1977). Lupus nephritis: Clinical course as related to morphologic forms and their transitions. Am. J. Med. 62, 12–30

    Article  PubMed  CAS  Google Scholar 

  3. Leehey, D. J., Katz, A. I. and Azaran, A. H. (1982). Silent diffuse lupus nephritis: long term follow up. Am. J. Kidney Dis. 2, (Suppl. 1), 188–196

    PubMed  CAS  Google Scholar 

  4. Bennett, W. M., Bardana, E. J. and Houghton, D. C. (1977). Silent renal involvement in systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 55, 420–428

    Article  PubMed  CAS  Google Scholar 

  5. Terai, C, Nojima, K. and Takano, A. (1987). Determination of urinary albumin excretion by radioimmunoassay in patients with subclinical lupus nephritis. Clin. Nephrol. 27 2, 79–83

    PubMed  CAS  Google Scholar 

  6. Adu, D., Williams, D.G. and Taube, D. (1983). Late onset systemic lupus erythematosus and Lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q. J. Med. 208 471–487

    Google Scholar 

  7. Appel, G. B., Silva, F. G. and Pirani, C. L. (1978). Renal involvement in systemic lupus erythematosus. A study of 56 patients. Medicine 57, 371–410

    Article  PubMed  CAS  Google Scholar 

  8. Cameron, J. S., Turner, D. R. and Ogg, C. S. (1979). Systemic lupus with nephritis: a long-term study. Q. J. Med. 189 1–24

    Google Scholar 

  9. Miller, M.H., Urowitz, M. B. and Gladman, D.D. (1983). Systemic lupus in males. Medicine 62, 5, 327–333

    Article  PubMed  CAS  Google Scholar 

  10. Yeung, C. K., Ng, W. L. and Wong, W. S. (1985). Acute deteriorations in renal function in systemic lupus erythematosus. Q. J. Med. 219 393–402

    Google Scholar 

  11. Ropes, M. W. (1964). Observations on the natural course of disseminated lupus erythematosus. Medicine 43, 387–391

    PubMed  CAS  Google Scholar 

  12. Hecht, B., Siegel, N. and Adler, S. (1976). Prognostic indices in lupus nephritis. Medicine 55, 2, 163–181

    Article  PubMed  CAS  Google Scholar 

  13. Donadio, J.V., Burgess, J. H. and Holley, K. E. (1977). Membranous lupus nephropathy: a clinicopathological study. Medicine 56, 6, 527–536

    Article  PubMed  Google Scholar 

  14. Banfi, G., Mazzucco, G. and Di Belgiojoso, G. B. (1985). Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome. Q. J. Med. 217 153–168

    Google Scholar 

  15. Tateno, S., Kobayashi, Y. and Hidekazu, S. (1983). Study of lupus nephritis: its classification and the significance of subendothelial deposits. Q. J. Med. 207 311–331

    Google Scholar 

  16. Donadio, J.V. (1984). Cytotoxic drug treatment of lupus nephritis. N. Engl. J. Med. 311 8, 528–529

    Article  PubMed  Google Scholar 

  17. Austin, H.A., Muenz, L. R. and Joyce, K. M. (1984). Diffuse proliferative lupus nephritis: identification of specific pathological features affecting renal outcome. Kidney Int. 25, 689–695

    Article  PubMed  Google Scholar 

  18. Magil, A.B., Ballon, H.S. and Chan, V. (1984). Diffuse proliferative lupus glomerulonephritis. Medicine 63, 4, 210–220

    Article  PubMed  CAS  Google Scholar 

  19. Glassock, R. J., Cohen, A. H. and Adler, S. G. (1986). Secondary glomerular diseases. In Brenner and Rector (eds.) The Kidney 3rd Edn. (Philadelphia: W. B. Saunders)

    Google Scholar 

  20. Balow, J. E., Austin, H.A. and Muenz, L. R. (1984). Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N. Engl. J. Med. 311 8, 491–495

    Article  PubMed  CAS  Google Scholar 

  21. Wagner, L. (1976). Immunosuppressive agents in lupus nephritis: a critical analysis. Medicine 55, 3, 239–250

    Article  PubMed  CAS  Google Scholar 

  22. Felson, D. T. and Anderson, J. (1984). Evidence for superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. N. Engl. J. Med. 311 24, 1528–1533

    Article  PubMed  CAS  Google Scholar 

  23. Urowitz, M.B., Gladman, D.D. and Tozman, E.C. (1984). The lupus activity criteria count (LACC). J. Rheumatol. 11 783–787

    PubMed  CAS  Google Scholar 

  24. Kinlen, L. J., Sheil, A. G. R. and Peto, J. (1979). Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J. 2, 1461–1416

    Article  PubMed  CAS  Google Scholar 

  25. Elliott, R.W., Essenhigh, D.M. and Morley, A.R. (1982). Cyclosphosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. Br. Med. J. 284 1160–1161

    Article  CAS  Google Scholar 

  26. Gonzalez-Dettoni, H. and Tron, F. (1985). Membranous glomerulopathy in SLE. Adv. Nephrol. 14, 347–364

    CAS  Google Scholar 

  27. The Southwest Paediatric Nephrology Study Group (1986). Comparisons of idiopathic and lupus membranous nephropathy in children. Am. J. Kidney Dis. 7 (2), 115–124

    Google Scholar 

  28. Kimberley, R.P., Lockshin, M.D. and Sherman, R. L. (1981). High dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am. J. Med. 70, 817–824

    Article  Google Scholar 

  29. Ponticelli, C., Zucchelli, P. and Banfi, G. (1982). Treatment of diffuse proliferative lupus nephritis by intravenous high dose methyl prednisolone. Q. J. Med. 201 16–24

    Google Scholar 

  30. Wei, N., Klippel, J. H. and Huston, D.P. (1983). Randomised trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1, 17–21

    Article  PubMed  CAS  Google Scholar 

  31. Verrier Jones, J., Cumming, R. H. and Bucknall, R. C. (1976). Plasmapheresis in the management of acute systemic lupus erythematosus. Lancet 1, 709–711

    Google Scholar 

  32. Lockwood, C.M., Rees, A.J. and Russell, B. (1977). Experience of the use of plasma exchange in the management of potentially fulminating glomerulonephritis and SLE. Exp. Haemtol. 5, 117–136

    Google Scholar 

  33. Verrier Jones, J., Cumming, R.H. and Bacon, P.A. (1979). Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q. J. Med. 48 555–576

    Google Scholar 

  34. Leaher, B. R., Becker, G.J. and Dowliner, J.P. (1986). Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin. Nephrol. 25, (5), 236–244

    Google Scholar 

  35. Llach, F. (1985). Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 28 429–439

    Article  PubMed  CAS  Google Scholar 

  36. Hughes, G. R. V. (1983). Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br. Med. J. 287 1088–1089

    Article  CAS  Google Scholar 

  37. Editorial (1984). Lupus anticoagulant. Lancet 1, 1157–1158

    Google Scholar 

  38. Jungers, P., Liote, F. and Dautzenberg, M.D. (1984). Lupus anticoagulant and thrombosis in systemic lupus erythematosus. Lancet 1, 574–575

    Article  PubMed  CAS  Google Scholar 

  39. Mansilla-Tinoco, R., Harland, S.J. and Ryan, P.J. (1982). Hydralazine, anti-nuclear antibodies, and the lupus syndrome. Br. Med. J. 284 936–939

    Article  CAS  Google Scholar 

  40. Batchelor, J.R., Welsh, K.I. and Mansilla-Tinoco, R. (1980). Hydralazine induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1, 1107–1109

    Article  PubMed  CAS  Google Scholar 

  41. Bjorck, S., Westberg, G. and Svalander, C. (1983). Rapidly progressive glomerulonephritis after hydralazine, Lancet 2, 42

    Article  PubMed  CAS  Google Scholar 

  42. Kincaid Smith, P. and Whitworth, J.A. (1983). Hydralazine-associated glomerulonephritis. Lancet 2, 348

    Article  PubMed  CAS  Google Scholar 

  43. Sim, E., Gill, E.W. and Sim, R. B. (1984). Drugs that induce systemic lupus erythematosus inhibit complement component C4. Lancet 2, 422–424

    Article  PubMed  CAS  Google Scholar 

  44. Fielder, A. H. L., Walport, M. J. and Batchelor, J. R. (1983). Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4a and C4b. Br. Med. J. 286 425–428

    Article  CAS  Google Scholar 

  45. Friou, G.J., Finch, S.C. and Detri, K.D. (1958). Interaction of nuclei with globulin from lupus erythematosus serum demonstrated with fluorescent antibody. J. Immunol 80, 324–329

    PubMed  CAS  Google Scholar 

  46. Datta, S. K., Manny, N. and Andrzejewski, C. (1978). Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. J. Exp. Med. 147 854–871

    Article  PubMed  CAS  Google Scholar 

  47. Boumpas, D.T., Popovic, M. and Mann, D. L. (1986). Type C retrovirus of human T cell leukaemia family are not evident in patients with systemic lupus erythematosus. Arth. Rheum. 29, (2), 185–188

    Article  CAS  Google Scholar 

  48. Koffler, D., Agnello, V. and Thoburn, R. (1971). Systemic lupus erythematosus: prototype of immune complex nephritis in man. J. Exp. Med. 134 3, 169–179

    PubMed  CAS  Google Scholar 

  49. Glassock, R. J. (1981). Glomerulonephritis in systemic lupus erythematosus. Am. J. Nephrol 1, 53

    Article  Google Scholar 

  50. Abrass, C. K., Neis, J. M. and Louie, J. S. (1980). Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with SLE. Arthritis Rheum. 23 3, 273–282

    Article  PubMed  CAS  Google Scholar 

  51. Kumano, K., Sakai, T. and Mashimo, S. (1987). A case of recurrent lupus nephritis after renal transplantation. Clin. Nephrol 27 2, 94–98

    PubMed  CAS  Google Scholar 

  52. Faaber, P., Rijke, T. P. M. and van der Putte, L. B. A. (1986). Cross-reactivity of human and murine anti-DNA antibodies with heparan sulphate. J. Clin. Invest. 77 1824–1830

    Article  PubMed  CAS  Google Scholar 

  53. Asano, Y. and Nakamoto. Y. (1978). Avidity of anti-DNA antibody and glomerular immune complex localisation in lupus nephritis. Clin. Nephrol. 134–139

    Google Scholar 

  54. Cook, J.M., Kazatchkine, M.D. and Bourgeois, P. (1986). Anti C3b-receptor antibodies in patients with SLE. Clin. Immunol. Immunopathol. 38 1, 135–138

    Article  PubMed  CAS  Google Scholar 

  55. Jacob, L., Lety, M.A. and Bach, J.F. (1986). Human systemic lupus erythematosus sera contain antibodies against cell surface proteins that share epitopes with DNA. Proc. Natl Acad. Sci. USA 83 (18), 6970–6974

    Article  PubMed  CAS  Google Scholar 

  56. Schwartz, R. S. (1983). Monoclonal lupus autoantibodies. Immunol. Today 4, 3, 68–69

    Article  Google Scholar 

  57. Lafer, E. M., Rauch, J. and Andrzejewski, C. (1981). Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J. Exp. Med. 153 897–909

    Article  PubMed  CAS  Google Scholar 

  58. Hahn, B. and Ebling, F. (1984). Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J. Immunol. 132 187–190

    PubMed  CAS  Google Scholar 

  59. Morrow, W. J. W., Youinou, P. and Isenberg, D. A. (1983). Systemic lupus erythematosus: 25 years of treatment related to immunopathology. Lancet 1, 206–210

    Article  Google Scholar 

  60. Morrow, W.J.W., Isenberg, D.A. and Todd-Pokropek, A. (1982). Useful laboratory measurements in the management of systemic lupus erythematosus. Q. J. Med. 51 125–138

    PubMed  CAS  Google Scholar 

  61. Swaak, A. J. G., Groenwold, J. and Bronsweld, W. (1986). Predictive value of complement profiles and anti-ds DNA in systemic lupus erythematosus. Ann. Rheum. Dis. 45, 359–366

    Article  PubMed  CAS  Google Scholar 

  62. Rubin, L. A., Urowitz, M. B. and Gladman, D. D. (1985). Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q. J. Med. 216 55, 87–98

    Google Scholar 

  63. Correia, P., Cameron, J. S. and Lian, J.D. (1985). Why do patients with lupus nephritis die? Br. Med. J. 290 126–131

    Article  CAS  Google Scholar 

  64. Haider, Y. S. and Roberts, W. C. (1981). Coronary arterial disease in systemic lupus erythematosus. Am. J. Med. 70, 775–781

    Article  PubMed  CAS  Google Scholar 

  65. Harris, E. N., Gharavi, A. E. and Boey, M. L. (1983). Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2, 1211–1214

    Article  PubMed  CAS  Google Scholar 

  66. Jungers, P., Liote, F. and Dautzenberg, M.D. (1984). Lupus anticoagulant and thrombosis in systemic lupus erythematosus. Lancet 1, 574–575

    Article  PubMed  CAS  Google Scholar 

  67. Cohen, J., Pinching, A.J. and Rees, A.J. (1982). Infection and immunosuppression. Q. J. Med. 201, 1–15

    Google Scholar 

  68. Coplon, N. S., Diskin, C. J. and Petersen, J. (1983). The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N. Engl. J. Med. 308 4, 186–190

    Article  PubMed  CAS  Google Scholar 

  69. Cheigh, J.S., Stenzel, K.H. and Rubin, A. L. (1983). Systemic lupus erythematosus in patients with chronic renal failure. Am. J. Med. 75, 602–606

    Article  PubMed  CAS  Google Scholar 

  70. Correia, P., Cameron, J. S. and Oggk, C.S. (1984). End stage renal failure in systemic lupus erythematosus with nephritis. Clin. Nephrol. 22 6, 293–302

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Ballardie, F.W. (1989). Lupus Nephritis. In: Catto, G.R.D. (eds) Multisystem Diseases. New Clinical Applications: Nephrology, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2223-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2223-5_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7497-1

  • Online ISBN: 978-94-009-2223-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics